During the past decade, Amtel Hospital first Clinical LLC conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 4 clinical trials were completed, i.e. on average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Amtel Hospital first Clinical LLC" are "Angina Pectoris" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Community-acquired Pneumonia (CAP)" (1 trials), "Coronary Artery Disease" (1 trials) and "Hospital-acquired Pneumonia (HAP)" (1 trials). Many other conditions were trialed in "Amtel Hospital first Clinical LLC" in a lesser frequency.

Most popular intervention types in "Amtel Hospital first Clinical LLC" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "BIBF 1120 plus docetaxel" (1 trials), "EXPAREL 266 mg" (1 trials), "IV standard-of-care cephalosporin" (1 trials), "Placebo" (1 trials) and "Ranolazine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Amtel Hospital first Clinical LLC" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Amtel Hospital first Clinical LLC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Amtel Hospital first Clinical LLC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Amtel Hospital first Clinical LLC, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".